Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials
Min Wei,1 Dongmei Duan21Department of Orthopedics, 2Department of Traditional Chinese Medicine, People’s Liberation Army General Hospital, Beijing, People’s Republic of China Abstract: T-helper 17 (Th17) pathway plays an important and distinct role in autoimmunity and inflammatio...
Main Authors: | Wei M, Duan D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-monoclonal-antibodies-targeting-interleukin-17--peer-reviewed-article-DDDT |
Similar Items
-
The Relationship Between Interleukin-17 and Osteoporosis in Patients with Rheumatoid Arthritis
by: Sedef Akdeniz, et al.
Published: (2018-08-01) -
Polymorphism rs2275913 of Interleukin-17A is related to more intensive therapy with disease-modifying anti rheumatic drugs in Mexican patients with Rheumatoid Arthritis
by: Maximiliano García de la Peña, et al.
Published: (2017-04-01) -
The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases
by: Youngkyun Lee
Published: (2013-10-01) -
The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01) -
Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis
by: Jun-ichiro Kan, et al.
Published: (2016-09-01)